Alzamend Neuro, Inc.
Nasdaq · CIK 0001677077 · Fiscal year end 0430
Latest reported period: Latest published period
Operating Income
$-8.8M
Net Income
$-8.8M
Eps Basic
-2.63
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-8.8M | - | - |
| Net Income | $-8.8M | - | - |
| Eps Basic | -2.63 | - | - |
| Eps Diluted | -2.63 | - | - |
| Cash And Equivalents | $710,689 | - | - |
| Total Assets | $2.1M | - | - |
| Total Liabilities | $1.3M | - | - |
| Shareholders Equity | $733,211 | - | - |
| Operating Cash Flow | $-8.1M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-K | Alzamend Neuro, Inc. | 2026-07-22 | 0001214659-26-008832 |
| 4 | Alzamend Neuro, Inc. | 2026-04-16 | 0001214659-26-004742 |
| 10-Q | Alzamend Neuro, Inc. | 2026-03-11 | 0001214659-26-003166 |
| 4 | Alzamend Neuro, Inc. | 2025-12-30 | 0001214659-25-018631 |
| 4 | Alzamend Neuro, Inc. | 2025-12-23 | 0001214659-25-018437 |
| 10-Q | Alzamend Neuro, Inc. | 2025-12-09 | 0001214659-25-017793 |
| 4 | Alzamend Neuro, Inc. | 2025-10-24 | 0001214659-25-015288 |
| 4 | Alzamend Neuro, Inc. | 2025-10-10 | 0001214659-25-014861 |
| 4 | Alzamend Neuro, Inc. | 2025-10-08 | 0001214659-25-014752 |
| 4 | Alzamend Neuro, Inc. | 2025-10-03 | 0001214659-25-014629 |
| 4 | Alzamend Neuro, Inc. | 2025-09-30 | 0001214659-25-014420 |
| 4 | Alzamend Neuro, Inc. | 2025-09-25 | 0001214659-25-014210 |
| 4 | Alzamend Neuro, Inc. | 2025-09-23 | 0001214659-25-014056 |
| 4 | Alzamend Neuro, Inc. | 2025-09-19 | 0001214659-25-013976 |
| 10-Q | Alzamend Neuro, Inc. | 2025-09-10 | 0001214659-25-013609 |
| 4 | Alzamend Neuro, Inc. | 2025-08-01 | 0001214659-25-011356 |